SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-146100
Filing Date
2023-05-16
Accepted
2023-05-16 16:08:57
Documents
14
Period of Report
2023-05-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d507685d8k.htm   iXBRL 8-K 31990
2 EX-10.1 d507685dex101.htm EX-10.1 6853
  Complete submission text file 0001193125-23-146100.txt   206118

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amam-20230515.xsd EX-101.SCH 3657
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amam-20230515_def.xml EX-101.DEF 14155
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amam-20230515_lab.xml EX-101.LAB 23900
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amam-20230515_pre.xml EX-101.PRE 14993
8 EXTRACTED XBRL INSTANCE DOCUMENT d507685d8k_htm.xml XML 6169
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma Inc. (Filer) CIK: 0001836056 (see all company filings)

IRS No.: 571147346 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40505 | Film No.: 23927545
SIC: 2836 Biological Products, (No Diagnostic Substances)